GFAP and astrocytoma (excluding glioblastoma): The MMP-2 (Figure 1C) and GFAP (Figure 1D) proteins did not demonstrate any statistically significant expression differences between different malignancy grades and different IDH1 mutational status astrocytoma groups, or between the astrocytoma and healthy control groups.